[go: up one dir, main page]

EG18175A - Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions - Google Patents

Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions

Info

Publication number
EG18175A
EG18175A EG18087A EG18087A EG18175A EG 18175 A EG18175 A EG 18175A EG 18087 A EG18087 A EG 18087A EG 18087 A EG18087 A EG 18087A EG 18175 A EG18175 A EG 18175A
Authority
EG
Egypt
Prior art keywords
prophylaxis
treatment
compounds
preparing
agents containing
Prior art date
Application number
EG18087A
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of EG18175A publication Critical patent/EG18175A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
EG18087A 1986-03-27 1987-03-25 Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions EG18175A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863610391 DE3610391A1 (en) 1986-03-27 1986-03-27 COMPOUNDS WITH NOOTROPPER ACTION, THESE CONTAINERS AND THEIR USE IN THE TREATMENT AND PROPHYLAXIS OF COGNITIVE DYSFUNCTIONS

Publications (1)

Publication Number Publication Date
EG18175A true EG18175A (en) 1994-07-30

Family

ID=6297417

Family Applications (1)

Application Number Title Priority Date Filing Date
EG18087A EG18175A (en) 1986-03-27 1987-03-25 Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions

Country Status (25)

Country Link
EP (1) EP0243645B1 (en)
JP (1) JPS62240698A (en)
KR (1) KR870008841A (en)
CN (1) CN1031267C (en)
AT (1) ATE102954T1 (en)
AU (1) AU621278B2 (en)
CA (1) CA1341064C (en)
CS (2) CS276179B6 (en)
DD (1) DD280765A5 (en)
DE (2) DE3610391A1 (en)
DK (1) DK172221B1 (en)
EG (1) EG18175A (en)
ES (1) ES2061447T3 (en)
FI (1) FI91876C (en)
HU (2) HU202118B (en)
IE (1) IE62456B1 (en)
MA (1) MA20919A1 (en)
NO (1) NO178546C (en)
NZ (1) NZ219764A (en)
OA (1) OA08506A (en)
PH (1) PH27210A (en)
PT (1) PT84564B (en)
RU (1) RU1836335C (en)
TN (1) TNSN87045A1 (en)
ZA (1) ZA872230B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231084A (en) * 1986-03-27 1993-07-27 Hoechst Aktiengesellschaft Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
AU612137B2 (en) * 1987-04-27 1991-07-04 E.R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing an ace inhibitor
DE3731085A1 (en) * 1987-09-16 1989-04-06 Hoechst Ag NEW AMINO ACID ESTERS, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
DE3739690A1 (en) * 1987-11-24 1989-06-08 Hoechst Ag STABILIZED MEDICINAL PRODUCTS, METHOD FOR THEIR PRODUCTION AND STABLE MEDICAL PREPARATIONS
DE3801587A1 (en) * 1988-01-21 1989-08-03 Hoechst Ag NEW AMINO ACID GLYCERIDES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THEM AND THE USE THEREOF
EP0331609A3 (en) * 1988-01-27 1992-07-01 Hoechst Aktiengesellschaft Angiotensin converting enzyme inhibitors having psychotropic effects
DE3803225A1 (en) * 1988-02-04 1989-08-17 Hoechst Ag AMINO ACID AMIDE WITH PSYCHOTROPIC EFFECT, METHOD FOR THE PRODUCTION THEREOF, AGENTS CONTAINING THE SAME AND THEIR USE
JPH01275529A (en) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc Suppressing treatment agent of delayed motion effect
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
US5093129A (en) * 1989-01-30 1992-03-03 E. R. Squibb & Sons, Inc. Method for treating addiction to a drug of abuse employing an ace inhibitor
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
CA2442717A1 (en) * 2001-03-15 2002-09-26 Saegis Pharmaceuticals, Inc. Methods for restoring cognitive function following systemic stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174844D1 (en) * 1980-10-23 1986-07-24 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3300774A1 (en) * 1983-01-12 1984-07-12 Hoechst Ag, 6230 Frankfurt NEW SPIROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AND NEW SPIROCYCLIC AMINO ACIDS AS INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CS212687A3 (en) 1992-04-15
PT84564A (en) 1987-04-01
PH27210A (en) 1993-05-04
FI871304A0 (en) 1987-03-25
PT84564B (en) 1989-11-10
AU7064987A (en) 1987-10-01
CN1031267C (en) 1996-03-13
FI91876B (en) 1994-05-13
NZ219764A (en) 1990-11-27
NO871282D0 (en) 1987-03-26
EP0243645A3 (en) 1990-01-24
ES2061447T3 (en) 1994-12-16
DK153587D0 (en) 1987-03-26
CS276179B6 (en) 1992-04-15
HU202118B (en) 1991-02-28
DE3789330D1 (en) 1994-04-21
IE62456B1 (en) 1995-02-08
FI91876C (en) 1994-08-25
CN87102304A (en) 1987-12-30
TNSN87045A1 (en) 1990-01-01
DD280765A5 (en) 1990-07-18
IE870784L (en) 1987-09-27
JPS62240698A (en) 1987-10-21
HU203117B (en) 1991-05-28
NO178546B (en) 1996-01-08
DE3610391A1 (en) 1987-10-08
KR870008841A (en) 1987-10-21
AU621278B2 (en) 1992-03-12
DK153587A (en) 1987-09-28
CS651989A3 (en) 1992-05-13
EP0243645B1 (en) 1994-03-16
CS276385B6 (en) 1992-05-13
OA08506A (en) 1988-07-29
EP0243645A2 (en) 1987-11-04
MA20919A1 (en) 1987-10-01
RU1836335C (en) 1993-08-23
HU896609D0 (en) 1990-02-28
HUT46046A (en) 1988-09-28
FI871304A (en) 1987-09-28
DK172221B1 (en) 1998-01-12
NO871282L (en) 1987-09-28
CA1341064C (en) 2000-08-01
ATE102954T1 (en) 1994-04-15
NO178546C (en) 1996-04-17
ZA872230B (en) 1987-09-21

Similar Documents

Publication Publication Date Title
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
GR860571B (en) Labdan-derivatives process for their preparation and their use as medicaments
EG18175A (en) Process for the preparing of compounds having a cognition adjuvant action, agents containing them and the use thereof in the treatment and prophylaxis of cognitive dysfunctions
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
GB8829839D0 (en) Chemical compounds
IL89031A0 (en) Medicaments containing a benzamide for the treatment or prevention of cognitive disorders and their preparation
ES8503643A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
ZA886459B (en) Use of bezafibrate for treating diabetes
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
JO1516B1 (en) Compounds having a congnition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions
MTP1001B (en) Compounds having a cognition adjuvant action,agents containing them,and the use of there of for treatment and prophylaxis of cognitive dysfunctions (hoe 86/f069)
GR3006610T3 (en)
YU44569B (en) Process for treatment of used catalyzer containing vanadium